Blood pressure variability

There are 140 papers on blood pressure variability in aging research: 11 trials and 91 observational studies in people, 7 in animals, 31 reviews. The newest story, Nov 7, 2026: “Wearable data predicted blood pressure crises 72 hours ahead”.

Biomarker

140 papers study it141 more mention it118 findings

30 new papers in 30 daysSee all 281 papers on blood pressure variability

At a glance

Higher blood pressure variability is linked with cognitive decline, dementia, frailty, cardiovascular events and mortality in human cohorts. A study in people with chronic kidney disease shows no clear link with frailty. A human trial finds no clear effect of sodium reduction or the DASH diet on blood pressure variability.

118 findings in 76 papers from 2007 to 2026, 14 of them since April 2026

“In the intensive treatment group, either systolic or diastolic BPV was no association with clinical outcomes(P≥0.30).”
Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP TrialHypertension (Dallas, Tex. : 1979)2023doi:10.1161/hypertensionaha.122.20376
  • Human trial11
  • Humans91
  • Animals7

Interventions

6

Amlodipine

no changein humans1downin mice1

2 studies
  1. Amlodipine was not clearly linked with blood pressure variability in humans (Systolic BPV: 11.4 vs. 10.5 mmHg, p=0.5; diastolic BPV: 8.47 vs. 8.65 mmHg, p=0.88).

    “Our prospective pilot study did not detect a significant difference in BPV between participants receiving amlodipine and other antihypertensive medications.”

    HumansHypertension and at least mild white matter hyperintensity; comparison with other antihypertensive medications31 daysn = 30

    Effects of amlodipine on blood pressure variability in subjects with white matter hyperintensity

    Frontiers in stroke

  2. Amlodipine decreases blood pressure variability in BPH/2J mice.

    “Amlodipine normalized SBP over the entire life span and decreased blood pressure variability.”

    Animalsin BPH/2J mice10 mg/kg per day

    Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice

    Journal of hypertension

More on Amlodipine

Sodium reduction

no changein humans1

1 study
  1. Sodium reduction showed no clear effect on blood pressure variability in the DASH-Sodium trial (difference in VIM for week-to-week systolic BP: 0.31, 95% CI -0.10-0.72).

    “In the DASH-Sodium trial, VIM at higher and lower sodium levels did not differ (e.g. difference in VIM for week-to-week systolic BP: 0.31, 95% CI -0.10-0.72)”

    Human trialin the DASH-Sodium trial

    Effects of dietary patterns and sodium intake on blood pressure variability: results from the DASH and DASH-sodium trials

    Journal of hypertension

More on Sodium reduction

Dash diet

no changein humans1

1 study
  1. Dash diet showed no clear effect on blood pressure variability in humans (difference in systolic VIM: 0.49, 95% CI -0.05-1.03).

    “there was no difference in week-to-week systolic BPV (difference in systolic VIM: 0.49, 95% CI -0.05-1.03) or 24-h systolic BPV (difference in systolic VIM: 0.37, 95% CI -0.13-0.87) between the DASH and Control diet groups”

    Human trial

    Effects of dietary patterns and sodium intake on blood pressure variability: results from the DASH and DASH-sodium trials

    Journal of hypertension

More on Dash diet

Amlodipine + benazepril

downin humans1

1 study
  1. Amlodipine + benazepril decreases blood pressure variability in humans (hypertension and PPH).

    “greater reductions in BPV”

    Human trialhypertension and PPH6 monthsn = 150

    Amlodipine-Benazepril Therapy for Blood Pressure Variability and Prognosis in Elderly Patients with Postprandial Hypotension

    Journal of visualized experiments : JoVE

More on Amlodipine + benazepril

Perindopril + amlodipine

downin humans1

1 study
  1. Perindopril + amlodipine decreases blood pressure variability in humans (arterial hypertension).

    “the fixed-dose combination (FC) amlodipine/perindopril has demonstrated a unique capability for reducing all types of BPV (visit-to-visit, day-to-day, during 24 h).”

    Reviewarterial hypertensionfixed-dose combination

    What do we Mean by "Ideal" Blood Pressure Control?

    Kardiologiia

More on Perindopril + amlodipine

Combination therapy

downin rats1

1 study
  1. Combination therapy decreases blood pressure variability in rats.

    “Meanwhile, only the combination treatment significantly decreased the BPV levels for the same period.”

    Animals

    Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats

    Acta pharmacologica Sinica

More on Combination therapy

Effects

22

Cognitive function

no changein humans1downin humans1

2 studies
  1. Blood pressure variability was not clearly linked with cognitive function in humans (p = .569, p = .280).

    “variability in systolic (p=.569) and diastolic (p=.280) BP was not significantly associated with MoCA scores.”

    Humansn = 502

    REFINING BP MONITORING: IMPACT OF HYPERTENSION AND VARIABILITY ON COGNITIVE TEST PERFORMANCE IN OLDER ADULTS

    GSA 2024 abstract

  2. Blood pressure variability is linked with worse cognitive function in humans (adjusted β = -9.50, 95% CI -14.71 to -4.28).

    “late-life visit-to-visit SBP variability was associated with orientation (adjusted β = -2.99, 95% CI -4.84 to -1.14), recall (adjusted β = -1.69, 95% CI -2.89 to -0.48), language (adjusted β = -2.26, 95% CI -4.13 to -0.38), and total (adjusted β = -9.50, 95% CI -14.71 to -4.28)”

    Humans

    Association between blood pressure control status, visit-to-visit blood pressure variability, and cognitive function in elderly Chinese: A nationwide study

    Frontiers in public health

Peak expiratory flow

downin humans1

1 study
  1. Blood pressure variability is linked with lower peak expiratory flow in humans (β = -0.224, 95% CI: -0.323 to -0.126).

    “increased BPV was significantly associated with faster lung function decline [β for systolic BP: -0.224, 95% confidence interval (CI): -0.323 to -0.126”

    Humans

    Sex modifies the association between blood pressure variability and lung function decline among population over 45 years old: a pooled analysis of two national cohorts

    Journal of thoracic disease

More on Peak expiratory flow

Falls

no changein humans1HR 0.97

1 study
  1. Blood pressure variability was not clearly linked with falls in humans (treated hypertension) (HR 0.97 (0.62-1.51)).

    “and 0.97 (0.62-1.51) for mean systolic BP, white coat effect, and SDIM, respectively.”

    Humanstreated hypertensionn = 499

    Home blood pressure monitoring and the risk of falls in older adults with hypertension: The AMBROSIA-HOME study

    American heart journal plus : cardiology research and practice

Heart rate variability

downin humans1

1 study
  1. Blood pressure variability is linked with lower heart rate variability in hypertensive patients.

    “The high-BPV group showed significantly reduced HRV across all indices”

    Humansin hypertensive patientsn = 198

    Elevated blood pressure variability links cardiac autonomic dysfunction to complex arrhythmias in hypertension

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society

More on Heart rate variability

Cardiovascular disease risk prediction accuracy

upin humans1

1 study
  1. Blood pressure variability is linked with better cardiovascular disease risk prediction accuracy in humans (cardiovascular disease risk prediction model) (C-index 0.833 vs 0.716).

    “Incorporating VVV BPV improved the prediction of CVD risk in people aged 55 years.”

    Humanscardiovascular disease risk prediction modeln = 3,065

    Incorporation of Visit-to-Visit Blood Pressure Variability into Cardiovascular Disease Risk Prediction

    medRxivPreprint

Endothelial injury

upin reviews1

1 study
  1. Blood pressure variability increases endothelial injury (independent of mean blood pressure).

    “acts as a pathogenic mechanism independent of mean blood pressure to exacerbate endothelial injury and cause target organ damage.”

    Reviewindependent of mean blood pressure

    Research progress on the correlation between blood pressure variability and hypertensive microvascular disease

    Frontiers in cardiovascular medicine

Glial fibrillary acidic protein

no changein humans1

1 study
  1. Blood pressure variability was not clearly linked with glial fibrillary acidic protein in humans.

    “adjusted for age, sex, and average systolic blood pressure, but not GFAP.”

    Humansn = 105

    Blood Pressure Dynamic Instability and Neurodegeneration in Older Adults

    AAIC 2025 abstract

More on Glial fibrillary acidic protein

NfL

upin humans1

1 study
  1. Blood pressure variability is linked with higher NfL in humans.

    “The interactive effect was also significantly associated with increased plasma NfL ( p = .009) such that individuals with the highest ARV and AASI had the highest NfL ( p = .01)”

    Humansn = 105

    Blood Pressure Dynamic Instability and Neurodegeneration in Older Adults

    AAIC 2025 abstract

More on NfL

Entorhinal cortex volume

downin humans1

1 study
  1. Blood pressure variability is linked with lower entorhinal cortex volume in humans.

    “and decreased left entorhinal cortex volume ( p = .01) in a region of interest analysis adjusted for age, sex, total intracranial volume and average systolic blood pressure”

    Humansn = 105

    Blood Pressure Dynamic Instability and Neurodegeneration in Older Adults

    AAIC 2025 abstract

Hippocampal volume

downin humans1

1 study
  1. Blood pressure variability is linked with lower hippocampal volume in humans.

    “The interaction between higher ARV and higher AASI was associated with decreased left ( p = .01) and right ( p = .02) hippocampal volumes”

    Humansn = 105

    Blood Pressure Dynamic Instability and Neurodegeneration in Older Adults

    AAIC 2025 abstract

Cardiovascular events

no changein humans1

1 study
  1. Blood pressure variability showed no clear effect on cardiovascular events in humans (intensive treatment group) (P≥0.30).

    “In the intensive treatment group, either systolic or diastolic BPV was no association with clinical outcomes(P≥0.30).”

    Human trialintensive treatment groupn = 7,678

    Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial

    Hypertension (Dallas, Tex. : 1979)

More on Cardiovascular events

All 22

Upstream

4

Older age

upin humans1

1 study
  1. older age is linked with higher blood pressure variability in humans (hypertensive patients) (18.6% higher, 16.7±7.2 mm Hg, p<0.05).

    “Blood pressure variability in elderly patients was 18.6% higher than in middle-aged and amounted to 16.7+_7.2 mm Hg (p<0.05).”

    Humanshypertensive patients

    BLOOD PRESSURE VARIABILITY IN ELDERLY AND MIDDLE-AGED HYPERTENSIVE PATIENTS

    International Medical Herald

Frailty

no changein humans1

1 study
  1. Frailty was not clearly linked with blood pressure variability in humans (chronic kidney disease) (24-hour: 13.0±2.4% vs 14.4±2.8%).

    “Systolic BPV did not differ in the pre-frail/frail group (24-hour: 13.0±2.4%; day: 12.8±2.7%; night: 10.4±3.1%) compared to the non-frail group”

    Humanschronic kidney diseasen = 28

    Association between Blood Pressure Variability and frailty in Chronic Kidney Disease

    GSA 2025 abstract

Approaching death

upin humans1

1 study
  1. Approaching death is linked with higher blood pressure variability in humans (last 3-4 weeks of life) (increased by 30%).

    “Average weekly BP variability was stable until the last 3-4 weeks of life, at which point variability increased by 30% for both systolic and diastolic BP.”

    Humanslast 3-4 weeks of life3-4 weeksmalesn = 17,953

    Exploring the Dynamics of Week-to-Week Blood Pressure in Nursing Home Residents Before Death

    American journal of hypertension

Systemic lupus erythematosus

upin humans1

1 study
  1. Systemic lupus erythematosus is linked with higher blood pressure variability in humans.

    “BPV in SLE was elevated across all ages.”

    Humans

    Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus

    The Journal of rheumatology

More on Systemic lupus erythematosus

Associations

61

Mortality

upin humans5HR 1.18

5 studies
  1. Blood pressure variability is associated with mortality in humans (Maintenance hemodialysis; multivariable adjustment).

    “After multivariable adjustment, older age, shorter dialysis vintage, higher BPV, and lower serum sodium were associated with all-cause mortality.”

    HumansMaintenance hemodialysis; multivariable adjustmentn = 595

    Blood pressure variability and serum sodium for long-term mortality risk stratification in maintenance hemodialysis patients: a real-world retrospective cohort study

    Frontiers in medicine

  2. Blood pressure variability is associated with mortality in humans (hypertensive).

    “greater long-term variability in nighttime SBP and daytime DBP was significantly associated with higher mortality.”

    Humanshypertensivemedian follow-up of 32.0 monthsn = 727

    Blood pressure variability is an independent predictor of mortality in hypertensive patients aged 80 years and older, based on long-term ambulatory blood pressure monitoring

    medRxivPreprint

  3. Blood pressure variability is linked with a higher risk of mortality in humans after multivariable adjustment (HR = 1.18 per 1 SD, 95% CI = 1.01-1.37).

    “visit-to-visit DBP variability was related to higher all-cause (hazard ratio (HR) = 1.18 per 1 SD, 95% confidence interval (CI) = 1.01-1.37)”

    Humansafter multivariable adjustmentper 1 SD

    Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study

    American journal of hypertension

  4. Blood pressure variability is associated with mortality in humans.

    “evidence suggesting that blood pressure variability is associated with both vascular and all-cause mortality.”

    Review

    Blood pressure variability: a still underestimated topic

    Revista clinica espanola

  5. Blood pressure variability predicts mortality in humans.

    “higher short- and long-term BPV correlates with prevalent frailty and predicts incident frailty, cognitive decline, falls, cardiovascular events, renal progression, and mortality”

    Review

    Blood pressure variability and frailty: mechanisms, evidence, and clinical implications

    International urology and nephrology

Cardiovascular disease

upin humans5HR 1.29–1.89

5 studies
  1. Blood pressure variability is linked with a higher risk of cardiovascular disease in essential hypertension (adjusted HR 1.89, 95% CI 1.32-2.71).

    “High BPV was associated with a significantly greater incidence of MACE than low BPV (34.2% vs. 17.1%, p < 0.001) and remained an independent predictor (adjusted HR 1.89, 95% CI 1.32-2.71, p < 0.001).”

    Humansin essential hypertensionmedian follow-up of 4.2 yearsn = 500

    Twenty-Four-Hour Blood Pressure Variability Combined With Circadian Rhythm Patterns in Predicting Cardiovascular Events in Hypertensive Patients

    Journal of clinical hypertension (Greenwich, Conn.)

  2. Blood pressure variability predicts cardiovascular disease in humans (primary care patients).

    “Higher VVV BPV (SD, CV. ARV) was associated with increased CVD risk.”

    Humansprimary care patientsn = 3,022

    The minimum number of blood pressure measurements needed and thresholds for visit-to-visit blood pressure variability to predict cardiovascular disease in primary care patients

    medRxivPreprint

  3. Blood pressure variability is linked with a higher risk of cardiovascular disease in humans with target-organ damage (HR 1.29, 95% CI 1.05-1.59).

    “increment in average real variability (hazard ratio, 1.29; 95% confidence interval, 1.05-1.59; P=0.02) were associated with a greater risk of cardiovascular disease”

    Humanswith target-organ damage16 yearsn = 1,408

    Impact of Age and Target-Organ Damage on Prognostic Value of 24-Hour Ambulatory Blood Pressure

    Hypertension (Dallas, Tex. : 1979)

  4. Blood pressure variability predicts cardiovascular disease in humans.

    “BPV and TTR represent complementary, clinically meaningful measures that improve CV risk stratification beyond mean BP.”

    Review

    Reassessing blood pressure control: the role of long-term blood pressure variability and time in target range

    Blood pressure

  5. Blood pressure variability is associated with cardiovascular disease in humans.

    “Higher BPV has been associated with an increased risk of cardiovascular mortality, stroke, coronary events, and heart failure”

    Review

    Blood Pressure Variability (BPV) as a Novel Digital Biomarker of Multisystem Risk and Diagnostic Insight: Measurement, Mechanisms, and Emerging Artificial Intelligence Methods

    Biomedicines

More on Cardiovascular disease

Cognitive function

downin humans4

4 studies
  1. Blood pressure variability is associated with cognitive function in humans (β = -0.273, 95% CI -0.467 to -0.078, p = .006).

    “Greater BP variability was associated with lower global cognitive scores (β=‐0.273 [95% CI: ‐0.467 to ‐0.078], p = .006).”

    Humansn = 195

    Beyond Hypertension: 24hr Blood Pressure Variability and Cognition

    AAIC 2025 abstract

  2. Blood pressure variability is associated with cognitive function in humans (adjusted mean, -0.08; 95% CI, -0.13, -0.03).

    “Increasing 24-h systolic BP variability was associated with lower MMSE (adjusted mean, -0.08; 95% confidence interval [CI], -0.13, -0.03)”

    Humansn = 1,435

    Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence

    Journal of Alzheimer's disease : JAD

  3. Blood pressure variability is associated with cognitive function in humans (β -0.074; 95% CI -0.131 to -0.018).

    “Higher systolic and diastolic BPV was associated with lower cognitive scores at the end of follow-up.”

    Humans18 yearsn = 4,770

    Blood Pressure Variability and Cognition in Black and White Older Adults Over 18 Years of Follow-up: A Population-Based Cohort Study

    Neurology

  4. Blood pressure variability predicts cognitive function in humans.

    “higher short- and long-term BPV correlates with prevalent frailty and predicts incident frailty, cognitive decline, falls, cardiovascular events, renal progression, and mortality”

    Review

    Blood pressure variability and frailty: mechanisms, evidence, and clinical implications

    International urology and nephrology

Frailty

upin humans4HR 1.17

4 studies
  1. Blood pressure variability is linked with a higher risk of frailty in humans (HR 1.17, 95% CI 1.04-1.31).

    “Participants in the highest systolic BPV tertile were at higher risk of frailty compared to those in the lowest (referent) tertile of systolic BPV [Fried hazard ratio (HR) 1.17, 95% confidence interval (CI) 1.04-1.31”

    Humans

    Long-term blood pressure variability and frailty risk in older adults

    Journal of hypertension

  2. Blood pressure variability is linked with a higher risk of frailty in humans.

    “increased fluctuation of blood pressure in the elderly can increase their risk of developing debilitating syndrome”

    Humans

    Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly

    Medicine

  3. Blood pressure variability predicts frailty in humans.

    “higher short- and long-term BPV correlates with prevalent frailty and predicts incident frailty, cognitive decline, falls, cardiovascular events, renal progression, and mortality”

    Review

    Blood pressure variability and frailty: mechanisms, evidence, and clinical implications

    International urology and nephrology

  4. Blood pressure variability predicts frailty in humans.

    “increased Blood Pressure Variability (BPV) is associated with organ damage and exerts independent predictive value on several health outcomes: cardiovascular events, neurocognitive impairment, metabolic disorders and typical geriatric syndromes such as sarcopenia and frailty”

    Review

    Blood pressure variability: A potential marker of aging

    Ageing research reviews

Dementia

upin humans3OR 1.48

3 studies
  1. Blood pressure variability is associated with dementia in humans (OR 1.48, 95% CI 1.09-2.02).

    “Increasing 24-h systolic BP variability was associated with lower MMSE (adjusted mean, -0.08; 95% confidence interval [CI], -0.13, -0.03), and SRT (adjusted means ranged from -0.13 to -0.06; 95% CI ranging from -0.19 to -0.01) scores and 1.48-fold greater odds of dementia (95% CI, 1.09-2.02) regardless of BP level.”

    Humansn = 1,435

    Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence

    Journal of Alzheimer's disease : JAD

  2. Blood pressure variability is associated with dementia in humans.

    “Increased blood pressure variability (BPV) is associated with increased risk for dementia, independent of hypertension.”

    Review

    Blood Pressure Variability and Alzheimer Disease Biomarkers

    Hypertension (Dallas, Tex. : 1979)

  3. Blood pressure variability raises the risk of dementia in humans.

    “These fluctuations in blood pressure over various timescales have each been linked to increased risk for Alzheimer's disease and dementia”

    Review

    The utility of blood pressure variability as a biomarker

    AAIC 2025 abstract

More on Dementia

Cognitive decline

upin humans3OR 1.52

3 studies
  1. Blood pressure variability is associated with cognitive decline in humans (older adults with controlled BP) (OR 1.52, 95% CI: 1.18-1.96).

    “Logistic regression revealed higher ORs for cognitive decline with increased SD of daytime SBP (1.52 [95% CI: 1.18-1.96]; P = 0.001) and DBP (1.36 [95% CI: 1.09-1.71]; P = 0.007)”

    Humansolder adults with controlled BP4.98 yearsn = 206

    Association of Longitudinal Change in Ambulatory Blood Pressure With Cognitive Decline in Older Adults

    JACC. Advances

  2. Blood pressure variability predicts cognitive decline in humans.

    “BP variability independently predicts cognitive decline.”

    Review

    Epidemiological and clinical evidence on blood pressure management for the prevention of dementia: striving for a healthy 100-year life

    Hypertension research : official journal of the Japanese Society of Hypertension

  3. Blood pressure variability is associated with cognitive decline in humans.

    “Three reviews reported associations between higher BP variability and all-cause dementia, and 2 for cognitive decline.”

    Review

    Associations of Blood Pressure Parameters with Cognitive Decline and Dementia: A Systematic Review of Reviews

    American journal of hypertension

Alzheimer's disease

upin humans2

2 studies
  1. Blood pressure variability is associated with Alzheimer's disease in humans.

    “The increased risk for dementia associated with high BPV includes probable Alzheimer disease (AD) dementia”

    Review

    Blood Pressure Variability and Alzheimer Disease Biomarkers

    Hypertension (Dallas, Tex. : 1979)

  2. Blood pressure variability raises the risk of Alzheimer's disease in humans.

    “These fluctuations in blood pressure over various timescales have each been linked to increased risk for Alzheimer's disease and dementia”

    Review

    The utility of blood pressure variability as a biomarker

    AAIC 2025 abstract

More on Alzheimer's disease

Cognitive impairment

upin humans2OR 1.23

2 studies
  1. Blood pressure variability is linked with a higher risk of cognitive impairment in elderly patients with acute decompensated heart failure (OR 1.23, P < 0.01).

    “SD (OR: 1.23, P < 0.01), CV (OR: 1.12, P < 0.01), maximum (OR: 1.13, P < 0.001) and δ (OR: 1.07, P < 0.01) in DBP were significantly associated with the lowest quartile of MMSE score.”

    Humansin elderly patients with acute decompensated heart failuren = 245

    Day-to-Day Blood Pressure Variability and Cognitive Function in the Elderly With Acute Heart Failure

    American journal of hypertension

  2. Cognitive impairment is associated with blood pressure variability in older patients in long-term care hospitals.

    “The mean BP was lower, but BP variability was higher in patients with cognitive impairment.”

    Humansin older patients in long-term care hospitalsn = 394

    Analysis of blood pressure and blood pressure variability pattern among older patients in long-term care hospitals: an observational study analysing the Health-RESPECT (integrated caRE Systems for elderly PatiEnts using iCT) dataset

    Age and ageing

More on Cognitive impairment

Cerebral perfusion

downin humans2

2 studies
  1. Blood pressure variability is associated with cerebral perfusion in humans (β = -.60 [95% CI -.90, -.30]; p < .001).

    “Elevated systolic blood pressure variability was related to lower levels of concurrent cerebral perfusion in medial temporal regions: hippocampus (β = -.60 [95% CI -.90, -.30]; p < .001)”

    Humansindependent of average blood pressure, white matter hyperintensities, and gray matter volumehippocampus

    Selective vulnerability of medial temporal regions to short-term blood pressure variability and cerebral hypoperfusion in older adults

    Neuroimage. Reports

  2. Blood pressure variability is associated with cerebral perfusion in humans (without dementia) (ß = -.48, p < 0.001).

    “For every SD increase in BPV, perfusion decreased in medial orbitofrontal cortex (ß = -.36; p = 0.008), hippocampus (ß = -.37; p = 0.005), entorhinal cortex (ß = -.48; p < 0.001)”

    Humanswithout dementia12 months

    Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults

    Neurobiology of aging

More on Cerebral perfusion

Epicardial fat thickness

upin humans1

1 study
  1. Epicardial fat thickness predicts blood pressure variability in humans (healthy young adults) (R2 = 0.110, p = 0.002).

    “EFT, smoking, and platelet/basophil ratio predicted nighttime systolic BPV (R2 = 0.110, p = 0.002).”

    Humanshealthy young adultsn = 172

    Epicardial Fat Thickness and Nighttime Systolic Blood Pressure Variability in Healthy Young Adults

    Research SquarePreprint

  2. Epicardial fat thickness is associated with blood pressure variability in humans (healthy young adults) (r = 0.193, p = 0.012).

    “EFT was significantly correlated with 24-hour systolic BPV (r = 0.171, p = 0.028), 24-hour diastolic BPV (r = 0.173, p = 0.025), nighttime systolic BPV (r = 0.193, p = 0.012)”

    Humanshealthy young adultsn = 172

    Epicardial Fat Thickness and Nighttime Systolic Blood Pressure Variability in Healthy Young Adults

    Research SquarePreprint

More on Epicardial fat thickness

All 61

Funding

13 grants since 2017

National Institute of Neurological Disorders and Stroke$2.6MNational Institute on Aging$975KJapan Society for the Promotion of Science¥16.6M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human study associates greater blood pressure variability with higher cardiovascular disease risk in essential hypertension. Reviews also link blood pressure variability to dementia, Alzheimer's disease and stroke in humans.

  2. Summary written from the findings.

Latest

Dec 2025: 7Jan 2026: 5Feb 2026: 12Mar 2026: 14Apr 2026: 10May 2026: 4Jun 2026: 4Jul 2026: 4Aug 2026: 7Sep 2026: 8Oct 2026: 22Nov 2026: 13110 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Wearable data predicted blood pressure crises 72 hours ahead

In a separate validation group, the model detected 82.1% of crises; 31.6% of positive predictions corresponded to a crisis.In a separate validation group, the model detected 82.1% of crises; 31.6% of positive predictions corresponded to a crisis.

Cohort · 4,190 peopleBlood pressure
Complex Issues of Cardiovascular Diseases

Program improved thinking and blood pressure in Uzbekistan trial

Scores on a test of overall thinking rose about 2.2 points with the 12-week program versus 0.2 points with standard care alone.Scores on a test of overall thinking rose about 2.2 points with the 12-week program versus 0.2 points with standard care alone.

Randomized trial · 60 peopleInterventions
ESC Congress 2026 Abstract

High blood pressure linked to weaker brain fluid coordination

A case-control study of 48 people with high blood pressure and 19 controls linked weaker coordination between brain blood activity and fluid flow to poorer cognition.A case-control study of 48 people with high blood pressure and 19 controls linked weaker coordination between brain blood activity and fluid flow to poorer cognition.

Case-control studyMechanisms

See all 281 papers on blood pressure variability